Distribution of antinuclear antibody (ANA) patterns determined by indirect immunofluorescence in scleroderma patients with different patterns of nailfold microvascular damage (early, active, late) at the end of followup. Data are percentages.
| ANA Pattern | Nailfold Videocapillaroscopy Pattern | |||
|---|---|---|---|---|
| Early | Active | Late | Total | |
| Negative | 87.5 | 12.5 | 0.0 | 100 |
| Nucleolar | 0.0 | 50.0 | 50.0 | 100 |
| Homogeneous | 33.3 | 33.3 | 33.3 | 100 |
| Centromeric (anticentromere antibody-positive) | 41.2 | 41.2 | 17.6 | 100 |
| Speckled | 100.0 | 0.0 | 0.0 | 100 |
| Fine-speckled + nucleolar (Scl-70-positive) | 14.3 | 28.6 | 57.1 | 100 |
| Speckled + nucleolar (Scl-70-negative) | 33.3 | 66.7 | 0.0 | 100 |